Atorvastatin (Lipitor)
ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.
Atorvastatin (Lipitor)
ATI class: Antilipidemic / HMG-CoA reductase inhibitor
Action
- ATI/source-folder candidate for Atorvastatin (Lipitor); verify mechanism against the source table before validation.
Therapeutic use
- Review under Antilipidemics medication safety.
Nursing assessment
- Assess muscle pain, weakness, dark urine, liver labs, lipid response, and pregnancy status.
- Review alcohol use, liver disease history, and interacting medications.
- Assess adherence and cardiovascular risk-reduction teaching needs.
Administration
- Verify route against the order and source table.
Side effects
- Verify common side effects against the source table.
Adverse effects
- Myopathy
- Rhabdomyolysis
- Liver enzyme elevation
- Hepatotoxicity
- GI upset
Interactions
- Grapefruit products
- Strong CYP3A4 inhibitors
- Fibrates
- Niacin
- Cyclosporine
- Warfarin monitoring may be affected
Contraindications
- See source-specific contraindications and precautions before administration.
Precautions
- Pregnancy, breastfeeding, active liver disease, or unexplained persistent liver enzyme elevation.
- Use caution with heavy alcohol use, older adults, renal impairment in rhabdomyolysis risk, and interacting lipid drugs.
Client teaching
- Report unexplained muscle pain, weakness, fever, or dark urine.
- Avoid pregnancy and discuss contraception if relevant.
- Continue heart-healthy diet, activity, and follow-up labs.
Medication outcomes
- Therapeutic response with no priority adverse effects.
Antidote / rescue
- No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.
NCLEX priority cues
- Muscle pain with dark urine can indicate rhabdomyolysis.
- Pregnancy requires medication review.
- Lipid medications reduce long-term risk but do not treat acute chest pain.
Medication classes
Source attribution
Related study cards
Shows the medication class, ATI cues, source references, and connected study cards for this drug.
Lowers cholesterol production or improves lipid profile to reduce long-term plaque and vascular risk.
ATI medication class concept.
ATI medication nursing assessment concept.
ATI medication nursing assessment concept.
ATI medication mechanism of action concept.
ATI medication client teaching concept.
ATI medication client teaching concept.
ATI medication interaction concept.
ATI medication interaction concept.
ATI medication adverse effect concept.
ATI medication interaction concept.
ATI medication adverse effect concept.